Trending...
- Netvantage SEO Launches Therapist SEO - 186
- Scarecrow Fest offers fall-themed activities at Frankenmuth River Place Shops - 177
- Pear Sperling Eggan & Daniels, P.C. Attorneys Recognized as 2025 Super Lawyers - 175
CANTON, Mich.--(BUSINESS WIRE)--TrialAssure® – a leading, global software company advancing clinical trial disclosure and data transparency – has released its latest version of ANONYMIZE for Documents, including the functionality to anonymize and redact PDF documents concurrently. Leveraging the power of the cloud for processing, this software has been shown to save as much as 80 percent of the effort involved in the redaction and anonymization process for PDFs based on flexible and reusable rule setting features – as compared to traditional manual redaction.
TrialAssure ANONYMIZE for Documents is a first-in-class document redaction and anonymization software that combines machine learning – a form of artificial intelligence (AI) - and natural language processing (NLP) to protect patient privacy by automatically finding, masking, anonymizing, or removing personal or company confidential information from unstructured text. Through a streamlined, configurable rules-based approach, ANONYMIZE for Documents is able to quickly process documents, including:
"We are seeing a dramatic increase in the need for clinical trial sponsors to complete new and retrospective anonymization of clinical documents," said Kelly Vaillant, Director of Global Transparency Strategy & Compliance, TrialAssure. "The impetus for document anonymization comes as increasing regulations from global health authorities and added pressure from advocacy groups push for the expanded utility of data for secondary research."
More on Michimich.com
Machine learning makes document transparency easier
Through machine learning and AI, TrialAssure ANONYMIZE for Documents uses NLP to extract information whenever text is transformed, and the system then feeds this data into powerful machine learning algorithms. In doing so, ANONYMIZE for Documents improves over time in identifying where and how text should be replaced.
Before finalizing changes, users are encouraged to review all suggested anonymizations within its unique user interface. In this most recent release, users are able to review, accept, and/or reject changes within the system. The system also auto-updates the rule set applied to the document based on reviewer feedback. This leads to greater efficiencies and data traceability.
"The future of clinical trials – especially as we move to a virtual or decentralized model – is dependent on the right technology to provide secure data sharing, while ensuring that the privacy of participants and company confidential information is respected," said Mohamad Zahreddine, Chief Information Officer, TrialAssure, and member of the Forbes Technology Council. "We are on a mission to ensure that the entire industry can be transparent, allowing for increased trust and improved lives, and to do that, we must start with correctly anonymizing your documents and data."
More on Michimich.com
Pharmaceutical companies, universities, and clinical research organizations (CROs) that want to stay in front of global anonymization regulations, including European Medicines Agency (EMA) Policy 0070 and Health Canada Public Release of Clinical Information (PRCI), can request a demo of ANONYMIZE for Documents at www.trialassure.com.
About TrialAssure
TrialAssure is a leading, global clinical trial disclosure and data transparency software suite with unmatched experience in helping navigate complex regulatory compliance challenges. TrialAssure provides fast, affordable, and informed technology and service solutions to help clinical trial sponsors meet clinical trial registration and results reporting, document and data anonymization, patient engagement, and compliance reporting goals. Established in 2009, TrialAssure regularly adapts to ever-changing clinical trial disclosure and data transparency requirements and was recently named Data Solution of the Year—Healthcare in the Data Breakthrough Awards. For more information, visit: www.trialassure.com or follow TrialAssure on LinkedIn.
TrialAssure ANONYMIZE for Documents is a first-in-class document redaction and anonymization software that combines machine learning – a form of artificial intelligence (AI) - and natural language processing (NLP) to protect patient privacy by automatically finding, masking, anonymizing, or removing personal or company confidential information from unstructured text. Through a streamlined, configurable rules-based approach, ANONYMIZE for Documents is able to quickly process documents, including:
- Clinical Study Reports (CSRs) and CSR amendments
- Clinical Study Protocols
- Statistical Analysis Plans (SAPs)
- Module 2-5 documents
- Patient Narratives
- Any other document formats including Adobe PDF and Microsoft Word
"We are seeing a dramatic increase in the need for clinical trial sponsors to complete new and retrospective anonymization of clinical documents," said Kelly Vaillant, Director of Global Transparency Strategy & Compliance, TrialAssure. "The impetus for document anonymization comes as increasing regulations from global health authorities and added pressure from advocacy groups push for the expanded utility of data for secondary research."
More on Michimich.com
- Your Body Isn't Broken—It's Out of Balance: The New Book Revealing the Blueprint to Restore Hormone Balance, Sleep, Gut & Metabolic Health
- Pastor Reeves Launches Pastor Reeves Studio: Original Christian Artwork Now Available Online
- Michigan Food as Medicine Summit to Bring Together Health, Policy, & Community Leaders Oct 7–8
- Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
Machine learning makes document transparency easier
Through machine learning and AI, TrialAssure ANONYMIZE for Documents uses NLP to extract information whenever text is transformed, and the system then feeds this data into powerful machine learning algorithms. In doing so, ANONYMIZE for Documents improves over time in identifying where and how text should be replaced.
Before finalizing changes, users are encouraged to review all suggested anonymizations within its unique user interface. In this most recent release, users are able to review, accept, and/or reject changes within the system. The system also auto-updates the rule set applied to the document based on reviewer feedback. This leads to greater efficiencies and data traceability.
"The future of clinical trials – especially as we move to a virtual or decentralized model – is dependent on the right technology to provide secure data sharing, while ensuring that the privacy of participants and company confidential information is respected," said Mohamad Zahreddine, Chief Information Officer, TrialAssure, and member of the Forbes Technology Council. "We are on a mission to ensure that the entire industry can be transparent, allowing for increased trust and improved lives, and to do that, we must start with correctly anonymizing your documents and data."
More on Michimich.com
- Roofman USA Expands Roofing Services Across Michigan, Adding Key Locations
- Roofman USA Highlights the Importance of Hiring Specialized Residential Roofers in Ann Arbor
- Wilderness Construction Offers Expert Guidance on Siding Color Selection for Ann Arbor Homeowners
- Japanese Martial Arts Center Promotes Karate as Stress Relief for Ann Arbor Adults
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
Pharmaceutical companies, universities, and clinical research organizations (CROs) that want to stay in front of global anonymization regulations, including European Medicines Agency (EMA) Policy 0070 and Health Canada Public Release of Clinical Information (PRCI), can request a demo of ANONYMIZE for Documents at www.trialassure.com.
About TrialAssure
TrialAssure is a leading, global clinical trial disclosure and data transparency software suite with unmatched experience in helping navigate complex regulatory compliance challenges. TrialAssure provides fast, affordable, and informed technology and service solutions to help clinical trial sponsors meet clinical trial registration and results reporting, document and data anonymization, patient engagement, and compliance reporting goals. Established in 2009, TrialAssure regularly adapts to ever-changing clinical trial disclosure and data transparency requirements and was recently named Data Solution of the Year—Healthcare in the Data Breakthrough Awards. For more information, visit: www.trialassure.com or follow TrialAssure on LinkedIn.
Filed Under: Business
0 Comments
Latest on Michimich.com
- John Thomas calls for unity and prayer after tragic loss
- Where the Miami Dolphins Stand After Week 1
- Which NFL Teams Can Rebound from Week 1? OddsTrader Breaks Down the Biggest Questions
- Apellix Deploys Breakthrough Spray-Painting Drones into Live Service Limited Beta Program Open for Advanced Contractors
- DivX Unveils New Educational Blog Series to Simplify MKV to MP4 Video Conversion
- CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
- Sheets.Market Brings Professional Financial Model Templates to Entrepreneurs and Startups
- Scarecrow Fest offers fall-themed activities at Frankenmuth River Place Shops
- Webinar Announcement: Investing in the European Defense Sector—How the New Era of Uncertainty Is Redefining Investment Strategies
- AEVIGRA (AEIA) Analysis Reveals $350 Billion Counterfeit Market Driving Luxury Sector Toward Blockchain Authentication
- Town Center Family Dental Highlights Why Dental Implants No Longer Feel Forceful
- Her Magic Mushroom Memoir Launches as a Binge-Worthy Novel-to-Podcast Experience
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
- Georgia Misses the Mark Again on Sports Betting, While Offshore Sites Cash In
- AAACF Annual Community Meeting Returns September 16: "Rising Together – Celebrating Our Collective Impact"
- $40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy
- Nashville International Chopin Piano Competition Partners with Crimson Global Academy to Support Excellence in Education
- AHRFD Releases Market Analysis: Cryptocurrency Market's Institutional Transformation Accelerating
- Ubleu Crypto Group Analyzes European Digital Asset Market Opportunities Amid Regulatory Evolution
- NIUFO Examines European MiCA Regulation's Impact on Digital Asset Trading Markets